Adaptive Biotechnologies Corporation
ADPT
$16.12
$0.100.62%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 71.68M | 93.97M | 58.88M | 52.44M | 47.46M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 71.68M | 93.97M | 58.88M | 52.44M | 47.46M |
| Cost of Revenue | -53.78M | 41.83M | 42.13M | 41.18M | -61.72M |
| Gross Profit | 125.46M | 52.15M | 16.75M | 11.26M | 109.18M |
| SG&A Expenses | 44.04M | 41.43M | 41.36M | 40.45M | 39.63M |
| Depreciation & Amortization | 429.00K | 428.00K | 423.00K | 419.00K | 428.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 84.45M | 83.68M | 83.92M | 82.05M | 81.30M |
| Operating Income | -12.77M | 10.29M | -25.04M | -29.60M | -33.84M |
| Income Before Tax | -13.58M | 9.55M | -25.59M | -29.83M | -33.72M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.58M | 9.55M | -25.59M | -29.83M | -33.72M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 0.00 | 1.00K | -21.00K | -22.00K | 25.00K |
| Net Income | -13.58M | 9.55M | -25.61M | -29.85M | -33.69M |
| EBIT | -12.77M | 10.29M | -25.04M | -29.60M | -33.84M |
| EBITDA | -8.58M | 14.70M | -20.53M | -24.87M | -29.39M |
| EPS Basic | -0.09 | 0.06 | -0.17 | -0.20 | -0.23 |
| Normalized Basic EPS | -0.06 | 0.04 | -0.11 | -0.13 | -0.15 |
| EPS Diluted | -0.09 | 0.06 | -0.17 | -0.20 | -0.23 |
| Normalized Diluted EPS | -0.06 | 0.04 | -0.11 | -0.13 | -0.15 |
| Average Basic Shares Outstanding | 153.13M | 152.43M | 152.08M | 149.20M | 147.68M |
| Average Diluted Shares Outstanding | 153.13M | 163.16M | 152.08M | 149.20M | 147.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |